✦ LIBER ✦

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ Scribed by A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MARENCO; P. GARBAGNOLI; M. ANDREONI; G. CARITI; G. CALLERI; M. SARTORI; S. CUSUMANO; A. GRASSO; R. RIZZI; M. GALLO; M. BASSO; M. ANSELMO; G. PERCARIO; G. CICCONE; M. RIZZETTO; G. SARACCO

Book ID: 108604735
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 464 KB
Volume: 24
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.03098.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: a randomized trial of pe

Clinical trial: a randomized trial of pegylated-interferon-α-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients

✍ P. LANGLET; F. D’HEYGERE; J. HENRION; M. ADLER; J. DELWAIDE; H. VAN VLIERBERGHE; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Pegylated α-interferon-2a plus ribavirin

Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

✍ Amparo Escudero; Felicidad Rodríguez; Miguel A Serra; Juan A Del Olmo; Francisco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

A randomized trial of induction doses of

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

✍ Annagiulia Gramenzi; Pietro Andreone; Carmela Cursaro; Gabriella Verucchi; Sergi 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 142 KB

Neutralizing antibodies to interferon-α

Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy*)

✍ Philippe Halfon; Sophie Pérusat; Marc Bourlière; Jean-Pierre Bronowicki; Pascale 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract A lack of antiviral response in patients with chronic hepatitis C treated with pegylated (PEG)‐interferon (IFN)‐α‐2a + ribavirin (RIBA) may be explained by neutralizing antibodies to IFN‐α‐2a. The aim of this study was to assess neutralizing antibodies to IFN‐α‐2a and IFN levels in non‐

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB